$ICCC 8-K SEC Filings

Filed On	Filing
13 Oct 2026	8-K: Results of Operations and Financial Condition ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results
13 Aug 2026	8-K: Results of Operations and Financial Condition
09 Jul 2026	8-K: Results of Operations and Financial Condition
17 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
10 Jun 2026	8-K: Regulation FD Disclosure
14 May 2026	8-K: Results of Operations and Financial Condition
08 May 2026	8-K: Entry into a Material Definitive Agreement
14 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
08 Apr 2026	8-K: Results of Operations and Financial Condition
18 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation
04 Mar 2026	8-K: Results of Operations and Financial Condition
09 Feb 2026	8-K: Departure/Election of Directors or Officers; Compensation
02 Feb 2026	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation
08 Jan 2026	8-K: Results of Operations and Financial Condition; Material Impairments +1 more
29 Dec 2025	8-K: Material Impairments; Other Events
13 Nov 2025	8-K: Results of Operations and Financial Condition
04 Nov 2025	8-K: Departure/Election of Directors or Officers; Compensation
07 Oct 2025	8-K: Results of Operations and Financial Condition
30 Sep 2025	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation
25 Aug 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

Comments